Alphatec Holdings Announces Pricing of Public Offering of Common Stock
16 Avril 2010 - 1:00PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures and markets products for the surgical
treatment of spine disorders, with a focus on treating conditions
related to the aging spine, announced that is has priced an
underwritten public offering of 16,000,000 shares of common stock,
consisting of 8,000,000 shares to be sold by the Company and
8,000,000 shares to be sold by a selling shareholder,
HealthpointCapital Partners, L.P., at a price to the public of
$5.00 per share. The net proceeds to the Company, after
underwriting discounts and commissions and estimated offering
expenses, are expected to be approximately $36.8 million. The
Company will not receive any proceeds from the sale of the shares
by the selling shareholder. The offering is expected to close on or
about April 21, 2010, subject to customary closing conditions.
Jefferies & Company, Inc. is acting as lead book-running
manager for the offering, with Canaccord Adams Inc. acting as joint
book-running manager and Cowen and Company, LLC and Lazard Capital
Markets LLC acting as co-managers. Alphatec Holdings and the
selling shareholder have each granted the underwriters a 30-day
option to purchase up to an additional 1,200,000 shares (2,400,000
shares in the aggregate) of common stock to cover over allotments
of shares, if any.
The securities described above are being offered pursuant to a
shelf registration statement previously filed with and declared
effective by the Securities and Exchange Commission on April 9,
2010. Copies of the final prospectus supplement relating to these
securities, when available, may be obtained from Jefferies &
Company, Inc., Attention: Syndicate Prospectus Department, 520
Madison Avenue, New York, NY, 10022 and at (888) 449-2342. This
press release shall not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or other jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to the registration or qualification under the securities laws of
any such state or other jurisdiction.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec
Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device
company that designs, develops, manufactures and markets products
for the surgical treatment of spine disorders, primarily focused on
the aging spine. The Company's mission is to combine world-class
customer service with innovative, surgeon-driven design that will
help improve the aging patient's quality of life. The Company is
poised to achieve its goal through new solutions for patients with
osteoporosis, stenosis and other aging spine deformities, improved
minimally invasive products and techniques and integrated biologics
solutions. In addition to its U.S. operations, the Company also
markets its products in over 50 international markets through its
subsidiary, Scient'x S.A., via a direct salesforce in France, Italy
and the United Kingdom and via independent distributors in the rest
of Europe, the Middle East and Africa, South America and Latin
America. In Asia and Australia, the Company markets its products
through its subsidiary, Alphatec Pacific, Inc, and through
Scient'x's distributors in China, Korea and Australia.
The Alphatec Holdings, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3520
CONTACT: Alphatec Spine, Inc.
Peter C. Wulff, Chief Financial Officer
(760) 494-6746
investorrelations@alphatecspine.com
Westwicke Partners
Lynn C. Pieper
(415) 202-5678
lynn.pieper@westwicke.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024